image credit- shutterstock
Vyome Holdings, Inc., a US-based clinical-stage healthcare holding company, and Pune-based Embryyo Technologies have announced the signing of a Memorandum of Understanding (MoU) to jointly pursue the global artificial intelligence (AI)-enabled medical device market.
This partnership will combine Vyome's healthcare industry experience and resources with Embryyo's medical technology capabilities to potentially productise and commercialise smart medical devices that can transform the standard-of-care in disease management and treatment.
As part of this partnership, Vyome and Embryyo will host a global AI-enabled medical device innovation forum for companies along the US-India corridor.
"We are currently developing a portfolio of transformative medical devices spanning interventional oncology, surgery, wearables, and drug delivery, and Vyome’s access to global capital markets and the US healthcare ecosystem will accelerate our mission to push the frontiers of medicine and elevate standards of care in healthcare globally,” said Nishant Kumar, Co-Founder and CEO of Embryyo Technologies.
